Oral sphingosine 1-phosphate (S1P) 1 and 5 receptor agonist Zeposia (ozanimod) achieved all its targets in the True North trial involving adults with moderate-to-severe ulcerative colitis ...

Ukrainian special forces have released several excerpts from a purported diary it said was found on a North Korean soldier killed in front-line fighting in Russia. North Korean leader Kim Jong Un ...

Bristol-Myers Squibb’s multiple sclerosis therapy ozanimod has been approved by the FDA right on schedule, but the company has put the launch on ice while it waits for the coronavirus pandemic ...

There is a risk North Korea may try to exploit the domestic political turmoil in South Korea and it is in Washington's interest to help resolve the issue, U.S. national security adviser Jake ...

Homegrown private equity firm True North, which has made several monetisation moves in the last two years while also slashing the target corpus of its seventh flagship fund, has laid the groundwork to ...

Newsweek magazine delivered to your door Newsweek Voices: Diverse audio opinions Enjoy ad-free browsing on Newsweek.com Comment on articles Newsweek app updates on-the-go ...

Baylor aims to register its sixth victory in seven games when it battles Arizona State in Big 12 play on Saturday night in ...

One of the more surprising transfer portal entrants this offseason, Alabama Crimson Tide inside linebacker Justin Okoronkwo ...

North Korea says it tested hypersonic intermediate-range missile aimed at remote Pacific targets © 2025 NBCUniversal Media, LLC ...